The Scientific Leadership Council of the Pulmonary Hypertension Association

The scientific program of the Pulmonary Hypertension Association is guided by the association's Scientific Leadership Council. The Council includes the following health care professionals:

• Vallerie V. McLaughlin, MD, SLC Chair, University of Michigan Health System, Ann Arbor, Michigan

• David B. Badesch, MD, SLC Immediate Past Chair, University of Colorado Health Sciences Center, Denver, Colorado

• John H. Newman, MD, SLC Chair Elect, Vanderbilt Medical School, Nashville, Tennessee

• Robyn J. Barst, MD, New York, New York

• Raymond L. Benza, MD, University of Alabama Health System, Birmingham, Alabama

• Todd Bull, MD, University of Colorado Health Sciences Center, Denver, Colorado

• Richard N. Channick, MD, UCSD Medical Center, San Diego, California

• C. Gregory Elliott, MD, LDS Hospital, University of Utah School of Medicine, Salt Lake City, Utah

• Karen A. Fagan, MD, University of South Alabama College of Medicine, Mobile, Alabama

• Adaani Frost, MD, Baylor College of Medicine, Houston, Texas

• John Granton, MD, Toronto General Hospital, Toronto, Canada

• Nazzareno Galiè, MD, Institute of Cardiology, University of Bologna, Bologna, Italy

• Nicholas S. Hill, MD, Division of Pulmonary, Critical Care and Sleep Medicine, Tufts-New England Medical Center, Boston, Massachusetts

• Marius Hoeper, MD, Hannover Medical school, Hannover, Germany

• Dunbar Ivy, MD, University of Colorado Health Sciences Center, Denver, Colorado

• Zhi-Cheng Jing, MD, Fu wai Heart Hospital, Beijing, China

• Anne M. Keogh, MD, St. Vincent's Public Hospital, Sydney, Australia

• Michael J. Krowka, MD, Mayo Clinic, Rochester, Minnesota

• James E. Loyd, MD, Vanderbilt University Medical Center, Nashville, Tennessee

• Michael D. McGoon, MD, Chair, PHA Board of Trustees, Pulmonary Hypertension Clinic, Mayo Clinic, Rochester, Minnesota

• Srinivas Murali, MD, Allegheny General Hospital, Pittsburgh, Pennsylvania

• Ronald J. Oudiz, MD, Liu Center for Pulmonary Hypertension, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California

• Marlene Rabinovitch, MD, Stanford University School of Medicine, Stanford, California

• Erica Berman-Rosenzweig, MD, Columbia-Presbyterian Medical Center, New York, New York

• Ivan M. Robbins, MD, SLC Scientific Sessions Committee, Vanderbilt University, Nashville, Tennessee

• Julio Sandoval, MD, Cardiopulmonary Department, National Institute of Cardiology of Mexico, Tlalpan, Mexico

• Richard Silver, MD, Medical University of South Carolina, Charleston, South Carolina

• Victor F. Tapson, MD, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina

Liaisons

• Arlene Schiro, RN, MA, ACNP-BC Chair, PH Resource Network, Massachusetts General Hospital, Boston, Massachusetts

• Joanne Sperando Schmidt, Patient Liaison

Emeritus Members

• Bruce H. Brundage, MD St. Charles Medical Center-Bend, Bend, Oregon

• Alfred P. Fishman, MD, University of Pennsylvania Health System, Philadelphia, Pennsylvania

The Mission of the Scientific Leadership Council is to provide medical and scientific guidance and support to the PHA by:

• Developing and disseminating knowledge for diagnosing and treating pulmonary hypertension

• Advocating for patients with pulmonary hypertension

• Increasing involvement of basic and clinical researchers and practitioners

More information on PHA's Scientific Leadership Council and associated committees can be found at: www.PHAssociation.org/SLC/